HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to slash liver cancer recurrence after surgery
Disease control Not yet recruitingThis study tests whether combining local treatments (TACE or ablation) with immunotherapy drugs (sintilimab and ipilimumab) before surgery can reduce the high risk of liver cancer returning. About 105 adults with resectable liver cancer at intermediate-to-high recurrence risk wil…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New combo therapy aims to shrink advanced liver and kidney tumors
Disease control Not yet recruitingThis study tests a new drug called WGI-0301 combined with the immunotherapy nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe and can shrink tumors. About 230 adults aged 18 to 75 will take part, and the study does not use a p…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Can Pre-Surgery immunotherapy stop liver cancer from coming back?
Disease control Not yet recruitingThis study tests whether giving an immunotherapy drug (atezolizumab) before surgery can boost the immune system's ability to fight liver cancer and lower the chance of the cancer returning. About 30 adults with early-stage liver cancer who are scheduled for liver removal will rec…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: University of Geneva, Switzerland • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC